help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rier, S. E.
Right arrow Articles by Becker, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rier, S. E.
Right arrow Articles by Becker, J. L.

Journal of Clinical Endocrinology & Metabolism, Vol 80, 1431-1437, Copyright © 1995 by Endocrine Society


ARTICLES

Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis

SE Rier, PN Zarmakoupis, X Hu and JL Becker
Department of Medical Microbiology, University of South Florida College of Medicine, Tampa 33606, USA.

Endometriosis (EM) is characterized by the aberrant growth of endometrial cells at sites outside the uterus. We showed previously that peritoneal leukocyte interleukin-6 (IL-6) production is altered in women with EM relative to that in normal control women. Because studies suggest that IL-6 may be growth regulatory for endometrial cells, we examined IL-6 and IL-6 soluble receptor (IL-6sR) in the peritoneal fluid of 40 women. In addition, the growth responsiveness of ectopic endometrial stromal cells to IL-6 was evaluated. The severity of EM correlated with increased levels of IL-6 accompanied by decreased IL- 6sR in peritoneal fluid (controls, 1.0 +/- 0.1 and 525.4 +/- 53; stage I-II EM, 1.4 +/- 0.2 and 274.6 +/- 26; stage III-IV EM, 19.3 +/- 4.6 and 319.4 +/- 26; adhesions, 1.9 +/- 0.4 and 324.7 +/- 26 pmol/L IL-6 and IL-6sR, respectively). Additional studies revealed that unstimulated endometrial stromal cells from ectopic implants secreted this cytokine in vitro. Furthermore, these cells were resistant to growth inhibition induced by exposure to additional IL-6; this response correlated with weak expression of IL-6 receptor. Taken together, these findings lend further support to the hypothesis that dysregulation of IL-6 responses plays a role in the pathophysiology of EM.


This article has been cited by other articles:


Home page
Hum ReprodHome page
S. Martinez, N. Garrido, J.L. Coperias, F. Pardo, J. Desco, J.A. Garcia-Velasco, C. Simon, and A. Pellicer
Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis
Hum. Reprod., March 1, 2007; 22(3): 836 - 842.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
F. Demirturk, H. Aytan, A. C. Caliskan, P. Aytan, and D. R. Koseoglu
Effect of Peroxisome Proliferator--Activated Receptor-{gamma} Agonist Rosiglitazone on the Induction of Endometriosis in an Experimental Rat Model
Reproductive Sciences, January 1, 2006; 13(1): 58 - 62.
[Abstract] [PDF]


Home page
Reproductive SciencesHome page
M. Bhanoori, K. A. Babu, M. Deenadayal, S. Kennedy, and S. Shivaji
The Interleukin-6 -174G/C Promoter Polymorphism Is Not Associated With Endometriosis in South Indian Women
Reproductive Sciences, July 1, 2005; 12(5): 365 - 369.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Koshiba, J. Kitawaki, M. Teramoto, Y. Kitaoka, H. Ishihara, H. Obayashi, M. Ohta, H. Hara, T. Adachi, and H. Honjo
Expression of Allograft Inflammatory Factor-1 in Human Eutopic Endometrium and Endometriosis: Possible Association with Progression of Endometriosis
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 529 - 537.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Darai, R. Detchev, D. Hugol, and N. T. Quang
Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours
Hum. Reprod., August 1, 2003; 18(8): 1681 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
F. Wieser, G. Fabjani, C. Tempfer, C. Schneeberger, M. Sator, J. Huber, and R. Wenzl
Analysis of an Interleukin-6 Gene Promoter Polymorphism in Women With Endometriosis Polymorphism in Women With Endometriosis By Pyrosequencing
Reproductive Sciences, January 1, 2003; 10(1): 32 - 36.
[Abstract] [PDF]


Home page
Toxicol SciHome page
S. Rier and W. G. Foster
Environmental Dioxins and Endometriosis
Toxicol. Sci., December 1, 2002; 70(2): 161 - 170.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. Akoum, C. Lawson, S. McColl, and M. Villeneuve
Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro
Mol. Hum. Reprod., September 1, 2001; 7(9): 859 - 866.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Piva, G. M. Horowitz, and K. L. Sharpe-Timms
Interleukin-6 Differentially Stimulates Haptoglobin Production by Peritoneal and Endometriotic Cells in Vitro: A Model for Endometrial-Peritoneal Interaction in Endometriosis
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2553 - 2561.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. E. Rier, C. L. Coe, A. M. Lemieux, D. C. Martin, R. Morris, G. W. Lucier, and G. C. Clark
Increased Tumor Necrosis Factor-{{alpha}} Production by Peripheral Blood Leukocytes from TCDD-Exposed Rhesus Monkeys
Toxicol. Sci., April 1, 2001; 60(2): 327 - 337.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
D. Hornung, F. Bentzien, D. Wallwiener, L. Kiesel, and R.N. Taylor
Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid
Mol. Hum. Reprod., February 1, 2001; 7(2): 163 - 168.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. Shimoya, A. Moriyama, I. Ogata, T. Nobunaga, M. Koyama, C. Azuma, and Y. Murata
Increased concentrations of secretory leukocyte protease inhibitor in peritoneal fluid of women with endometriosis
Mol. Hum. Reprod., September 1, 2000; 6(9): 829 - 834.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Z. Yang, S. K. Agarwal, and W. G. Foster
Subchronic Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Modulates the Pathophysiology of Endometriosis in the Cynomolgus Monkey
Toxicol. Sci., August 1, 2000; 56(2): 374 - 381.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Carlberg, J. Nejaty, B. Froysa, Y. Guan, O. Soder, and A. Bergqvist
Elevated expression of tumour necrosis factor {alpha} in cultured granulosa cells from women with endometriosis
Hum. Reprod., June 1, 2000; 15(6): 1250 - 1255.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Akoum, C. Jolicoeur, and A. Boucher
Estradiol Amplifies Interleukin-1-Induced Monocyte Chemotactic Protein-1 Expression by Ectopic Endometrial Cells of Women with Endometriosis
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 896 - 904.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
A. Akoum, J. Lavoie, R. Drouin, C. Jolicoeur, A. Lemay, R. Maheux, and E. W. Khandjian
Physiological and Cytogenetic Characterization of Immortalized Human Endometriotic Cells Containing Episomal Simian Virus 40 DNA
Am. J. Pathol., April 1, 1999; 154(4): 1245 - 1257.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society